Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros


Bases de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Int J Lepr Other Mycobact Dis ; 60(3): 410-5, 1992 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-1474279

RESUMO

The bactericidal effect of a new quinolone, ofloxacin (OFLO), was determined on an established Mycobacterium leprae infection in nude mice. Various drug regimens, including combinations of drugs, were examined for different treatment periods. OFLO and rifampin (RMP) individually failed to produce significant killing after treatment with a single large dose. However, when single large doses of OFLO and RMP were given in combination, a 100-fold reduction in viability was achieved. For a longer period of treatment both of these drugs, at lower doses, produced a moderate reduction in viability. The addition of dapsone to the lower dose of OFLO resulted in a significant reduction in viability, while lower doses of RMP and OFLO together produced a moderate reduction in viability.


Assuntos
Hanseníase/tratamento farmacológico , Ofloxacino/uso terapêutico , Animais , Dapsona/uso terapêutico , Modelos Animais de Doenças , Quimioterapia Combinada , Camundongos , Camundongos Nus , Mycobacterium leprae , Rifampina/uso terapêutico , Teste Bactericida do Soro
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA